Triumph Over Hepatitis C ::. podcasts

Monday, January 02, 2006

Drug Company Ethics

BioTech 2005 ::: Panel Discussions of Drug Company use of Reps to Bribe Doctors
Click Image to Download Here to Stream,
Click Here for Audio Only

Filmed at the BioTech 2005 Counter Conference in Philadelphia between June 18th -21st; this panel discussion video features Dr. Adam Tsai, MD (Physicians for a National Health Program) and Pedro Rodriguez (Action Alliance of Senior Citizens). Drug Reps are a lazy doctors best friend. Get the perspective on drug company gifts to doctors and other heavy handed tactics Drug Companies use to push pills on the public for Profit with no regard to your health.

Related Links ::: Action Alliance of Senior Citizens, Hep C Solutions, Dennis Kucinich on Healthcare for All ~ RealVideo, Physicians for a National Health Program, Patents and blood cells, Pharmaceutical corporations accused of Genocide

25 Minutes QuickTime Video
StumbleUpon Toolbar Stumble It!


  • Appreciate your blog,i have a victims support page against Eli Lilly for it's defective Zyprexa product causing my diabetes.--Daniel Haszard

    By Blogger Danny Haszard, at 5/25/2006 1:16 PM  

Post a Comment

<< Home

Subscribe With Any RSS Reader
Add 'Triumph Over Hepatitis C ::: Audio Blog' to Newsburst from CNET

Get Lloyd's new book - Hepatitis C: A Do-It-Yourself Guide for Health
Lloyd's NEW
Hep C DIY Guide

It is not our intention or purpose to replace the service of a physician, nor is it our purpose to guarantee any medical or nutritional preparation or the effectiveness thereof. The information on this website is not presented with the intention of diagnosing or prescribing. It is intended to help those who wish to cooperate with their physician in a mutual desire to build and maintain health. We believe that in the event someone uses this information without his or her doctor's approval, doing this for him or herself, he or she is only exercising their constitutional right to pursue happiness. Therefore, the author, editors and publishers assume no responsibility